Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man

被引:296
作者
Bogaards, JJP
Bertrand, M
Jackson, P
Oudshoorn, MJ
Weaver, RJ
van Bladeren, PJ
Walther, B
机构
[1] TNO Pharma, Dept Kinet & Metab, NL-3700 AJ Zeist, Netherlands
[2] Technol Serv, Orleans, France
[3] Serv Res & Dev, Slough SL3 6HH, Berks, England
关键词
D O I
10.1080/00498250010021684
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. In the present study, nine cytochrome P450 enzyme activities in seven species were characterized to allow a practical means of comparing this important metabolic step between various test animals and man. 2. Enzyme activities and kinetic parameters were first determined towards marker substrates for human cytochrome P450 enzymes. Inhibition profiles were then determined with both antibodies directed against various cytochrome P450 enzymes and with chemical inhibitors. 3. Both the enzyme kinetic parameters/enzyme activities, and the inhibition profiles obtained for the animal species were compared with those obtained for human liver microsomes in order to postulate the animal species most similar to man with regard to each individual cytochrome P450 enzyme activity. 4. It was found that, as expected, none of the tested species was similar to man for all the measured P450 enzyme activities, but that in each species only some of the P450 enzyme activities could be considered as similar to man. 5. When it is known which human cytochrome P450 enzymes are involved in the metabolism of a compound, the comparative data presented here can be used for selecting the most suitable species for in vitro and in vivo experiments.
引用
收藏
页码:1131 / 1152
页数:22
相关论文
共 53 条
  • [1] Fatty acid ω- and (ω-1)-hydroxylation in experimental alcoholic liver disease:: Relationship to different dietary fatty acids
    Amet, Y
    Adas, F
    Nanji, AA
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (07) : 1493 - 1500
  • [2] Anzenbacher P, 1998, DRUG METAB DISPOS, V26, P56
  • [3] The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes
    Bogaards, JJP
    Venekamp, JC
    vanBladeren, PJ
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1996, 102 (03) : 169 - 182
  • [4] HUMAN CYTOCHROME-P450 ENZYME SELECTIVITIES IN THE OXIDATION OF CHLORINATED BENZENES
    BOGAARDS, JJP
    VANOMMEN, B
    WOLF, CR
    VANBLADEREN, PJ
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 132 (01) : 44 - 52
  • [5] SPECIES VARIATION IN THE RESPONSE OF THE CYTOCHROME P-450-DEPENDENT MONOOXYGENASE SYSTEM TO INDUCERS AND INHIBITORS
    BOOBIS, AR
    SESARDIC, D
    MURRAY, BP
    EDWARDS, RJ
    SINGLETON, AM
    RICH, KJ
    MURRAY, S
    DELATORRE, R
    SEGURA, J
    PELKONEN, O
    PASANEN, M
    KOBAYASHI, S
    ZHIGUANG, T
    DAVIES, DS
    [J]. XENOBIOTICA, 1990, 20 (11) : 1139 - 1161
  • [6] CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER
    BURKE, MD
    THOMPSON, S
    WEAVER, RJ
    WOLF, CR
    MAYER, RT
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) : 923 - 936
  • [7] EVALUATION OF TRIACETYLOLEANDOMYCIN, ALPHA-NAPHTHOFLAVONE AND DIETHYLDITHIOCARBAMATE AS SELECTIVE CHEMICAL PROBES FOR INHIBITION OF HUMAN CYTOCHROMES P450
    CHANG, TKH
    GONZALEZ, FJ
    WAXMAN, DJ
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 311 (02) : 437 - 442
  • [8] THE ROLE OF INDIVIDUAL HUMAN CYTOCHROMES-P450 IN DRUG-METABOLISM AND CLINICAL-RESPONSE
    CHOLERTON, S
    DALY, AK
    IDLE, JR
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (12) : 434 - 439
  • [9] METABOLIC POLYMORPHISMS
    DALY, AK
    CHOLERTON, S
    GREGORY, W
    IDLE, JR
    [J]. PHARMACOLOGY & THERAPEUTICS, 1993, 57 (2-3) : 129 - 160
  • [10] Daniel HI, 1996, PSYCHOPHARMACOL BULL, V32, P219